10x Genomics (TXG) Assets Average (2019 - 2026)

10x Genomics' Assets Average history runs 8 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• In Q1 2026, Assets Average rose 12.9% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 12.9% YoY), while the FY2025 annual figure was $980.0 million, up 4.05% from the prior year.
• Assets Average came in at $1.0 billion for Q1 2026 at 10x Genomics, down from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.0 billion in Q4 2025 to a low of $911.0 million in Q1 2025.
• A 5-year average of $978.0 million and a median of $998.9 million in 2022 frame the typical range for Assets Average.
• Across the five-year window, Assets Average decreased 7.58% in 2024 and increased 12.9% in 2026, its largest moves.
• 10x Genomics' Assets Average stood at $1.0 billion in 2022, then declined by 5.51% to $956.8 million in 2023, then dropped by 2.99% to $928.2 million in 2024, then climbed by 11.44% to $1.0 billion in 2025, then decreased by 0.56% to $1.0 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $1.0 billion, $1.0 billion, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison